| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | 0.03 | 0.6 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.6 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | 0.027 | 0.6 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |